| Video
What does the patient desire: elimination of pain or restoration of function? What does the practitioner think the patient wants? Pharmacists Lynn McPherson and Alexandra McPherson discuss.
| Video
Dr. Prasad discusses opioids vs nonpharmaceuticals, health costs vs benefits, pain scores vs daily functioning--and keeping the patient's needs uppermost in importance.
| Video
Are clinical treatment guidelines useful in actually treating patients? Dr. Argoff discusses the guideline development process, and why the individual patient sometimes gets "lost in translation".
| Video
The complex problems that opioid issues bring about are not easily solved. Jeremy A. Adler, MS, PA-C, of Pacific Pain Medicine Consultants, warns against looking for a single solution.
| Video
Dr. Date works at a county hospital in San Mateo, California. Although interdisciplinary teams should be the way to go, sometimes a lack of resources, and people, come into play and change the dynamic.
| Video
Dr. Date works at a county hospital in San Mateo, California, where a lack of practitioners and the limited resources of patients contribute to the pain management difficulties in this setting.
| Article
The value of topical analgesics as a safe and effective treatment alternative to opioids and prescription NSAIDs for chronic pain management has been confirmed in a new study led by PAINWeek faculty member Jeffrey Gudin, MD, director of pain and palliative care, Englewood Hospital, New Jersey. Dr...
| Video
New insights have been gained in realizing the importance of the skin in assessing and treating people with chronic pain. Drs Rice and Albrecht discuss the role of the skin as a functional organ for neural and vascular system interaction, and of keratinocytes in the development of pain. The...
| Video
A specialist in public policy and bioethics considers the conundrum of gaining insurance coverage for this cost-efficient but expensive paradigm change to prescribing decisions, as well as some of the ethical issues associated with the practice of pharmacogenomic testing.
| Video
Dr. Cuevas-Trisan discusses the emerging role of botulinum toxins as chemical neuromodulators, and their application to the management of chronic intractable pain syndromes.